Functional effects of a tissue-engineered cardiac patch from human induced pluripotent stem cell-derived cardiomyocytes in a rat infarct model

Stem Cells Translational Medicine

Volumn 4, Issue 11, 2015, Pages 1324-1332

  Wendel, Jacqueline S ^a   Ye, Lei ^b   Tao, Ran ^c   Zhang, Jianyi ^b   Zhang, Jianhua ^c   Kamp, Timothy J ^c   Tranquillo, Robert T ^a  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cardiac tissue engineering; Cardiomyocyte; Fibrin; Induced pluripotent stem cell; Pericyte

Indexed keywords

CELL NUCLEUS ANTIGEN; FIBRIN; KI 67 ANTIGEN; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENGRAFTMENT; FEMALE; FLOW CYTOMETRY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRACARDIAC PATCH; NONHUMAN; PERICYTE; PLURIPOTENT STEM CELL; RAT; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; DISEASE MODEL; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MYOCARDIAL INFARCTION; NUDE RAT; PATHOLOGY; TRANSPLANTATION; XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; HETEROGRAFTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, NUDE;

EID: 84945276149     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0044     Document Type: Article

References (39)

1. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics-2012 Update: A report from the American Heart Association. Circulation 2012;125:e2-e220.
2. Takahashi K, Tanabe K, OhnukiMet al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
3. Zhang J, Wilson GF, SoerensAGet al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009; 104:e30-e41.
4. Zhang L, Guo J, Zhang P et al. Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast. Circ Heart Fail 2015;8:156-166.
5. Zhang J, Klos M, Wilson GF et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: The matrix sandwich method. Circ Res 2012; 111:1125-1136.
6. Lian X, Zhang J, Azarin SM et al. Directed cardiomyocyte differentiation from human pluripotent stemcells bymodulatingWnt/β-catenin signaling under fully defined conditions. Nat Protoc 2013;8:162-175.
7. Anderson D, Self T, Mellor IR et al. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 2007;15: 2027-2036.
8. Huber I, Itzhaki I, Caspi O et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J 2007;21:2551-2563.
9. Elliott DA, Braam SR, Koutsis K et al. NKX2- 5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 2011;8:1037-1040.
10. Dubois NC, Craft AM, Sharma P et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 2011; 29:1011-1018.
11. Fong CY, Peh GS, Gauthaman K et al. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev 2009;5:72-80.
12. Ye L, Zhang S, Greder L et al. Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF. PLoS One 2013;8:e53764.
13. Tohyama S, Hattori F, Sano M et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013;12:127-137.
14. Ye L, Chang YH, Xiong Q et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 2014;15:750-761.
15. Chong JJ, Yang X, Don CW et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014;510:273-277.
16. Black LD III., Meyers JD, Weinbaum JS et al. Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng Part A 2009;15:3099-3108.
17. Wendel JS, Ye L, Zhang P et al. Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model. Tissue Eng Part A 2014;20: 1325-1335.
18. Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12: 452-458.
19. Zhang D, Shadrin IY, Lam J et al. Tissueengineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013;34: 5813-5820.
20. Tulloch NL, Muskheli V, Razumova MV et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011;109:47-59.
21. Mihic A, Li J, Miyagi Y et al. The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cellderived cardiomyocytes. Biomaterials 2014;35: 2798-2808.
22. Nunes SS, Miklas JW, Liu J et al. Biowire:A platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 2013;10:781-787.
23. Hirt MN,Boeddinghaus J, MitchellA et al. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol 2014; 74:151-161.
24. Morin KT, Dries-Devlin JL, Tranquillo RT. Engineered microvessels with strong alignment and high lumen density via cell-induced fibrin gel compaction and interstitial flow. Tissue Eng Part A 2014;20:553-565.
25. Armulik A, Genové G, Betsholtz C. Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21:193-215.
26. Smith AO, Bowers SLK, Stratman AN et al. Hematopoietic stem cell cytokines and fibroblast growth factor-2 stimulate human endothelial cell-pericyte tube co-assembly in 3D fibrin matrices under serum-free defined conditions. PLoS One 2013;8:e85147.
27. Stratman AN, Schwindt AE, Malotte KM et al. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tubeassembly and stabilization. Blood 2010;116:4720-4730.
28. Chang WG, Andrejecsk JW, Kluger MS et al. Pericytes modulate endothelial sprouting. Cardiovasc Res 2013;100:492-500.
29. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324: 797-801.
30. Stratman AN, Malotte KM, Mahan RD et al. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009;114: 5091-5101.
31. Masumoto H, Ikuno T, Takeda M et al. Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci Rep 2014; 4:6716.
32. Liau B, Christoforou N, Leong KW et al. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 2011;32:9180-9187.
33. Reinecke H, Zhang M, Bartosek T et al. Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 1999;100: 193-202.
34. Chen CW, Okada M, Proto JD et al. Human pericytes for ischemic heart repair. Stem Cells 2013;31:305-316.
35. Caspi O, Lesman A, Basevitch Y et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007;100:263-272.
36. Xu C, Police S, Rao N et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-508.
37. Nadal-Ginard B, Kajstura J, Leri A et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003;92: 139-150.
38. Hein S, Arnon E, Kostin S et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: Structural deterioration and compensatory mechanisms. Circulation 2003;107: 984-991.
39. Helmbold P, Nayak RC, Marsch WC et al. Isolation and in vitro characterization of human dermal microvascular pericytes. Microvasc Res 2001;61:160-165.